Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Human medicine
Name of medicinal product: BIMATOPROST/TIMOLOL ELVIM
Active substances:
Timolol+Bimatoprost
Estonian, English, Latin
ATC code: S01ED82
Dosage form: eye drops, solution
Strength: 5mg+0,3mg 1ml
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):  (last updated April 5, 2022)
Package information leaflet (PIL): EST  (last updated April 5, 2022)
Labelling:  (last updated April 5, 2022)
Indication: Reduction of intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.
Safety features: Yes
Marketing authorization holder: SIA Elvim 
Marketing authorization number: 1058122 
Marketing authorization issued on: April 5, 2022 
Marketing authorization expires on: April 5, 2027 
Marketing authorization procedure type: Decentralised 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1843084  BIMATOPROST/TIMOLOL ELVIM  eye drops, solution  5mg +0,3mg 1ml 3ml 1TK  Prescription  100% 50%  7,50  20.12.2023     
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere